On ECHEMI
Home > Drugs > Polyostotic fibrous dysplasia
Polyostotic fibrous dysplasia
Polyostotic fibrous dysplasia, also known as Albright syndrome or McCune-Albright syndrome (MAS), was first described by McCune (1936) and Albright (1937). It is a bone growth and development disease with three main clinical symptoms: bone damage, precocious puberty and skin pigmentation. A small number of patients also have other endocrine abnormalities.
  • Site of disease:

    Bone Skin
  • Infectious :

    Not contagious
  • Frequent population:

    Children and adolescents
  • Related symptoms:

    Multiple nodules Muscle fiber size is unequal Bone pain Goiter Hypophosphatemia
  • Concurrent disease:

Related Drugs
Compound Panax Notoginseng Capsules
Manufacturer:

Jilin Luwang Pharmaceutical Co., Ltd.

Related Ingredients
  • Riligustilide list

    89354-45-0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.